August 2012
American Association of Nurse Anesthetists
Lewin contact: Paul Hogan
Certified Registered Nurse Anesthetists (CRNAs), educated with specialized training, skill, and expertise in pain management, provide chronic pain management in rural areas, underserved by physicians and healthcare facilities. CRNA services are often the sole source of chronic pain management services in these areas. If the patients are not able to access care from the local CRNAS, the alternatives are to travel great distances for care from physicians, to have expensive and invasive surgery, or to be institutionalized as a result of untreated pain.
The report discusses four case studies about four Medicare beneficiaries who are currently receiving pain treatment from their local (rural) CRNA. Each case discusses the costs – medical and indirect (non-medical and opportunity cost) – of the current treatment pathway, and alternative pathways that do not include access to a CRNA for chronic pain treatment.
Client Area: Associations
Expertise Area: Health Professionals Workforce
June 2011
Prepared for The American Association of Retired Persons (AARP), American Hospital Association, American Medical Association, American College of Cardiology, and LeadingAge
Lewin contact: John Sheils
The Lewin Group developed a case study for The American Association of Retired Persons (AARP), American Hospital Association, American Medical Association, American College of Cardiology, and LeadingAge, which analyzes the economic impacts of the “Commitment to American Prosperity Act” (CAP) being considered by Congress to limit the growth in Federal spending. The case study examines the impact that spending reductions would have on people who depend upon federal programs for income and healthcare. Because health care is such a large portion of federal spending, it also presents estimates of the impact that these cuts would have on health care provider revenues and the resulting effects on access to care for Medicare and Medicaid beneficiaries.
Client Area: Associations, Federal Government
Expertise Area: Health Reform
May 2011
Pennsylvania Coalition of Medical Assistance Managed Care Organizations
The Pennsylvania Coalition of Medical Assistance Managed Care Organizations (the Coalition) represents Pennsylvania’s Medical Assistance physical health managed care organizations that participate in the state’s HealthChoices program. Health Choices is the state’s large-scale capitated mandatory managed care program for Medical Assistance recipients. In 2005, the Coalition commissioned The Lewin Group to conduct a comparative evaluation of Pennsylvania’s HealthChoices program to the state’s traditional fee-for-service program as well as ACCESS Plus, the state’s enhanced primary care case management program, focusing on cost-effectiveness, impact on access, the quality of services provided, and the program’s focus on and approaches to serving individuals with special needs. In 2011, the Coalition asked Lewin to update the cost-effectiveness piece of the 2005 study in an effort to identify savings provided to Pennsylvania by HealthChoices when compared to traditional fee-for-service and to ACCESS Plus.
Client Area: Associations
Expertise Area: Medicaid and CHIP
June 2010
Prepared for: Advamed
Lewin Contact: Cliff Goodman
This report presents updated estimates of the medical technology industry’s (MTI) economic contributions from the previous industry analysis, which was released in 2007. The industry encompasses the manufacturing of everyday medical devices, such as contact lenses and thermometers, to high-tech equipment, such as implantable pacemakers, neurostimulators and state-of-the-art imaging systems. Each of the 50 States and the District of Columbia are benefitted by MTI establishments; nearly all have seen this industry grow since the 2007 report.
Client Area: Associations, Pharma / Bio / Device
January 2010
Lewin Contact: Cliff Goodman
Comparative effectiveness research (CER) is reshaping the evaluation of health care technology in the United States, with implications for innovation, regulation, payment, access, quality, and costs. The interest in CER arises from a widely perceived shortfall in evidence to inform decisions by clinicians, patients, health care provider organizations, and payers. The evidence expectations inherent in CER offer distinct challenges to the laboratory sector, as well as opportunities for those that can demonstrate the value of laboratory tests in the CER paradigm.
This report explains the rationale for CER, what CER is, and its significance for laboratory medicine. It describes the types of evidence generated by CER and how it compares with the evidence usually generated for regulatory purposes. The report summarizes current federal activities in CER that are relevant to laboratory medicine. Further, it describes implications of CER for the laboratory testing sector.
Client Area: Associations
Expertise Area: Comparative Effectiveness Research
September 2009
The paper is located here. The other link provides you a link to the web page for the conference and other materials.
Lewin Contact: Cliff Goodman
Client Area: Associations
Expertise Area: Comparative Effectiveness Research
September 2009
American Clinical Laboratory Association; Advanced Medical Technology Association (AdvaMed)
Lewin contact: Clifford Goodman
The contributions of clinical laboratory screening and diagnostic tests to health care quality and outcomes are substantial. These contributions were described in an earlier report from The Lewin Group, The Value of Diagnostics Innovation, Adoption, and Diffusion in Health Care (2005). This report updates key elements of that study, providing a current overview of the important role of laboratory screening and diagnostic tests in our health care system, today’s means of assessing value, and four case studies documenting value of specific tests to patient care.
Client Area: Associations
Expertise Area: Evidence-Based Medicine / HTA
July 2009
Medicaid Health Plans of America (MHPA); Association for Community Affiliated Plans (ACAP)
For MHPA and ACAP, The Lewin Group assessed the financial impact and administrative burden that out-of-network claims pose in Medicaid managed care. The report examined Medicaid non-emergency out-of-network payment policies in Arizona, California, Florida, Georgia, Maryland, Nebraska, New Jersey, New York, Pennsylvania, Tennessee, Texas and Wisconsin.
Client Area: Associations
Expertise Area: Medicaid and CHIP
June 2009
Pharmaceutical Research and Manufacturers of America (PhRMA)
PhRMA commissioned an evaluation of the degree to which changes in rebates for Medicare/Medicaid dual eligibles would create "spillover" impacts on the Part D premiums charged to other Medicare beneficiaries. Ingenix Consulting staff conducted modeling of various scenarios and Lewin staff prepared the written report. Our analyses estimate that if dual eligibles' prescriptions are paid for at Medicaid prices, additional costs will be imposed on Part D participants who are not dual eligibles. These increased monthly costs per beneficiary are estimated to range from $8 - $16, which constitutes an increase of 25% - 50% in the Part D premiums paid by non-dual eligibles.
Client Area: Associations
Expertise Area: Medicaid and CHIP, Medicare
March 2009
America's Health Insurance Plans (AHIP)
In 2004, America’s Health Insurance Plans engaged The Lewin Group to synthesize existing research on the savings achieved when states have implemented Medicaid managed care programs. This report is an update of the 2004 report, and includes both studies from the previous report and studies that have been released since 2004. In all, The Lewin Group reviewed 24 studies. The studies reviewed were identified and selected by America’s Health Insurance Plans and Lewin and include federally required independent assessments, studies commissioned by the federal and state governments, private foundations, and researchers, and one health plan-funded study. Studies are grouped into three categories: state studies, which examine states’ cost savings in their overall Medicaid managed care programs; targeted Medicaid managed care studies, which assess savings in Medicaid managed care programs targeted to specific populations; and specific service studies, which analyze Medicaid managed care program savings for specific services.
Client Area: Associations
Expertise Area: Medicaid and CHIP
Showing 1 to 10 of 86 item(s)